Literature DB >> 7296506

Local recurrence and survival in patients with (Clark Level IV/V and over 1.5-mm thickness) stage I malignant melanoma of the extremities after regional perfusion.

H Schraffordt Koops, H Beekhuis, J Oldhoff, J W Oosterhuis, E van der Ploeg, A Vermey.   

Abstract

During the period 1965-1974, 110 patients with stage I malignant melanoma of the extremities were treated by regional isolated perfusion with L-phenylalanine mustard and local excision. In order to study local recurrence and survival, only patients with a primary melanoma Clark Level IV or V and a tumor thickness of more than 1.5 mm were accepted in this study. The determinate survival in patients followed for 5-14 years in 78%; 17% developed positive regional lymph nodes. The local skin recurrence rate was 9% (9 patients); four of these 9 patients simultaneously had distant metastases; the other five patients are alive with NED after retreatment. This series of patients, too, shows that tumor thickness determines the prognosis, both as to local recurrence and as to survival. The mean tumor thickness in the hyperthermically perfused patients was found to clearly exceed that in the normothermically perfused, the mean values being 4.85 mm and 3.87 mm, respectively. Yet local recurrence and regional lymph node metastases proved to be less frequent after hyperthermic than after normothermic perfusion, although the difference was not statistically significant.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7296506     DOI: 10.1002/1097-0142(19811101)48:9<1952::aid-cncr2820480907>3.0.co;2-x

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Hyperthermic perfusion with chemotherapy for melanoma of the extremities.

Authors:  F Ghussen; I Krüger; R V Smalley; W Groth
Journal:  World J Surg       Date:  1989 Sep-Oct       Impact factor: 3.352

2.  Isolated regional perfusion in malignant melanoma of the extremities.

Authors:  H Schraffordt Koops; J Oldhoff; J W Oosterhuis; H Beekhuis
Journal:  World J Surg       Date:  1987-08       Impact factor: 3.352

3.  [Technic of isolated perfusion of the extremities. Experience with 171 cases].

Authors:  K Aigner; K Schwemmle
Journal:  Langenbecks Arch Chir       Date:  1983

4.  [Stroma-free hemoglobin solution and perfusion of isolated extremities].

Authors:  P Hild; K Schwemmle; E Zscherpe; F Pfannkuch
Journal:  Langenbecks Arch Chir       Date:  1984

5.  The joints of the evolving foot. Part III. The fossil evidence.

Authors:  O J Lewis
Journal:  J Anat       Date:  1980-09       Impact factor: 2.610

6.  Controversies concerning adjuvant regional isolated perfusion for stage I melanoma of the extremities.

Authors:  H Schraffordt Koops; B B Kroon; J Oldhoff; H J Hoekstra
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

7.  A prospective randomized study of regional extremity perfusion in patients with malignant melanoma.

Authors:  F Ghussen; K Nagel; W Groth; J M Müller; H Stützer
Journal:  Ann Surg       Date:  1984-12       Impact factor: 12.969

8.  The pharmacokinetic advantages of isolated limb perfusion with melphalan for malignant melanoma.

Authors:  R N Scott; D J Kerr; R Blackie; J Hughes; G Burnside; R M MacKie; D S Byrne; A J McKay
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.